Description
Tirzepatide is a dual GLP-1/GIP receptor agonist supporting clinically managed metabolic improvements. The 5 mg pen is typically used as an introductory dose in supervised programmes.
Details
Strength: 5 mg per pen
Route: Subcutaneous injection only
Storage: 2–8 °C.












Reviews
There are no reviews yet.